ClinicalTrials.gg
RecruitingNCT07912515Updated Nov 3, 2026

My Symptoms Young - a New Internet-based Programme for Young People With Persistent Physical Symptoms in Primary Care: Exploration of Effect and Health Literacy Characteristics Among Users

An interventional study of My Symptoms Young - an internet-based self-help programme for young people with persistent physical symptoms in Persistent Physical Symptoms (PPS), Bodily Distress Syndrome and Health Literacy, sponsored by Aarhus University Hospital. Recruiting at 1 site in Denmark. Open to participants aged 15 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by Aarhus University Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Nov 2025, registered Oct 2026).
  • Started Nov 2025; still recruiting 11 months later.
Updated Nov 3, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Not applicable
Ages
15 Years to 25 Years
Sex
All
01

Study summary

The research programme is an ambitious effort aiming to improve overall functioning and quality of life for young people with bodily distress. Bodily distress is a condition characterized by persistent physical symptoms (PPS), such as headache, nausea or abdominal pain, not explained by a well-defined disease. Over time, PPS can develop into a functional disorder, with detrimental impact on the young person's everyday life and opportunities. Thus, early intervention is crucial, but at present, access to specialized treatment of PPS to young people in primary care is very limited.

The investigators have developed the internet-based self-help programme My Symptoms Young as a new digital solution for early intervention of PPS. The intervention was developed using a high degree of user involvement (young people with PPS) and are now ready to be tested.

The goal of this clinical trial is to learn and preliminary test the possible effects of the internet-based self-help intervention program My Symptoms Young in young people aged 15-25 who experience PPS (physical symptoms presenting for >3 months). The main question the investigators aim to answer is:

  • What are the potential effects of My Symptoms Young In addition, the investigators aim to investigate if participation in the program can reduce overall symptom intensity and interference with daily activity in young people's lives. Finally, the investigators aim to examine if individual levels of health literacy (HL) and eHealth literacy (eHL) will modify the potential effects.
  • The primary outcomes will be symptom intensity and symptom interference with daily activities
  • The primary hypothesis will be: Symptom intensity and interference with daily activities will improve after the treatment with My Symptoms Young. The effect will be modified by levels of HL and aspects of eHL.

The investigators will include a total of 62 participants. The are no comparison group. Participants will be recruited from a health care professional in primary care (either general practitioner or practising pediatrician; from now on referred to as HCP). The HCP will determine whether referral to the My Symptoms Young programme is relevant. To guide this evaluation, the HCP will use pre-defined inclusion and exclusion criteria for participation. When a young person has been referred to the project group, a research assistent from the investigator group will contact the young person to provide more detailed information on the research project and the programme. If written consent is obtained, the young person will receive access to the programme. Throughout the intervention, the referring HCP is fully responsible for the health care of the young person. Referral and participation will be documented in the participants' primary care medical journal. If participants experience physical or psychological challenges during the project, they are advised to contact the referring HCP, i.e. the responsible healthcare provider.

The programme is accessed through a website, using either tablet, mobile or computer. It consists of seven modules, a closing module on relapse prevention, and a module targeting close relatives plus four tools: don't break the chain, goal setting staircase, symptom registration and notebook for reflections. The seven modules target symptom understanding, physical energy, resources and strains, thoughts, feelings, values, and self-care. Participants will gradually gain access to the modules. The programme encourages young persons to work with various exercises throughout the different modules but with freedom to choose what to work with. Besides text and exercises, the programme also includes explanatory animations, audio files on case stories, audio files on brief meditations and videos on physical exercises.

At first login (baseline), the participant will need to complete a set of questionnaires to access the programme. When completed the participant receives access to the programme. The researcher will follow up with participants by phone after one week if they have not logged into the programme and after three weeks if they have logged in but remained inactive. Participants can decide individually how long they wish to use the programme, but they are encouraged and recommended to engage actively at least twice a week for a minimum of 30 minutes. Participants will have access to the program for a total of 8 weeks. They will fill in questionnaires at three time points: Baseline (first login to the programme), End of Treatment (8 weeks after baseline) and 3 months after End of Treatment.

Read the detailed description

IDEA The research programme is an ambitious and dedicated effort aiming at the improvement of functioning and quality of life for young people with bodily distress. Bodily distress is a condition characterised by persistent physical symptoms (PPS) not explained by well-defined diseases. Over time, PPS can develop into a functional somatic disorder, with detrimental impact on the young person's everyday life and opportunities. Thus, early intervention is crucial, but at present, access to specialized treatment of PPS to young people in primary care is very limited.

The investigators have developed the internet-based self-help programme My Symptoms Young as a new digital solution for early intervention of bodily distress. The investigators have applied a high degree of user involvement (young people with PPS) in the development process and are now ready to test the possible impact of the resulting solution.

The present project will 1) test the impact of My Symptoms Young on young people (age 15-25 years) with PPS in primary care and 2) explore the influence of participants' health literacy (HL) and aspects of eHealth literacy (eHL) on their engagement with the programme and whether the level of HL and eHL modifies the impact. The latter might inform improvements regarding provision of adequate support for users with HL and eHL challenges.

BACKGROUND AND RATIONALE The decrease in mental well-being and the increase in distress among young people have become a critical public health concern. Young people with PPS such as pain and fatigue, which cannot be attributed to a specific well-defined disease, are common across various health care settings. Such symptoms are often an indicator of low mental well-being with different expressions of bodily distress, i.e. various physical responses to prolonged stress in susceptible individuals. PPS may cause school absence, high health-care costs, high medication use and low educational attainment. Additionally, PPS increases the risk of mental illnesses such as anxiety and depression. Furthermore, without intervention PPS may develop into severe functional somatic disorders (also classified as somatoform disorders in ICD-10/bodily distress disorder in ICD-11 or somatic symptom disorder in DSM-5), which often require resource-intensive specialized treatment in secondary care, including psychiatric settings.

Internet-based delivery methods allow for early provision of treatments otherwise only available in specialized care. The internet is prominent in young people's daily life and online resources e.g. mindfulness apps are publicly available but rarely target young people. Therefore, to address the treatment needs of youths (aged 15-25) with PPS in primary care, the investigators recently developed My Symptoms Young, a responsive application accessible via a web browser. Through user involvement, this internet-based intervention was redesigned from the existing My Symptoms programme for adults to meet the needs of young people. The content is mainly inspired by cognitive behavioral therapy and contains seven modules on symptom understanding, physical energy, resources and strains, values, thoughts, feelings, self-care, and in addition a closing module on relapse prevention. Furthermore, a module targeting close relatives is available to provide information and guide relatives on how to support participants to actively engage with the programme. Adherence is motivated by text message prompts 1-2 times a week. After a thorough usability evaluation My Symptoms Young is ready for the first clinical testing. However, the usability testing also revealed that some users can be challenged by understanding some of the provided information and exercises.

Health literacy (HL) may be an important precondition for young people's ability to engage with a treatment such as My Symptoms Young. Personal HL refers to individuals' ability to find, understand, and use information and services to inform health-related decisions and actions for themselves and others. Low HL has been linked to maladaptive health behavior and adverse illness perceptions in adults. In internet-based interventions active engagement depends not only on the abilities of the individual but also on the interaction between user and system as encompassed by the concept of eHealth Literacy (eHL). Thus, both HL and eHL characteristics in end users may be important to consider when testing and implementing a new eHealth intervention.

RESEARH AIMS, OVERALL STUDY DESIGN, AND METHODS Aim: To primarily test the possible effects of My Symptoms Young in young people with PPS.

Hypothesis: Symptom intensity and interference with daily activities will improve after the treatment with My Symptoms Young. The effect will be modified by levels of HL and aspects of eHL.

Study design: Open pilot study. Design and reporting will be in accordance with existing recommendations for non-randomized pilot studies.

Methods: 62 participants will receive questionnaires at three time points: Baseline (first login to the programme), End of Treatment (8 weeks after baseline) and 3 months after End of Treatment.

Primary outcomes will be symptom intensity and symptom interference with daily activities as measured by a numeric rating scale (NRS) ranging from 0 to 10. Secondary outcomes will reflect physical symptom burden, psychobehavioural features, health-related quality of life and satisfaction with the programme. HL and eHL measures at baseline will be applied as potential moderators of effect. Covariates will be participant sociodemographics, obtained at baseline, including data on age, gender, education, occupation/sick leave and self-reported chronic disease.

STUDY SETTING AND RECRUITMENT PROCEDURE The study is conducted in close collaboration with healthcare professionals (HCP) in primary care who are mostly likely to be in contact with young people with PPS in the early stage, namely general practitioners (GPs) and practicing pediatricians.

All recruiting HCPs will receive a guide outlining the information they must provide to participants during the recruitment process. Throughout the intervention, the referring HCP is fully responsible for the health care of the young person. Referral and participation will be documented in the participants' primary care medical journal. If participants experience physical or psychological challenges during the project, they are advised to contact the referring HCP, i.e. the responsible healthcare provider. This is also emphasized in the participant information.

RECRUITMENT PROCEDURE The recruitment procedure for the open pilot study can be divided in the following steps

  1. Young people with PPS will be recruited by a HCP in primary care. The HCP will determine whether referral to the My Symptoms Young programme is relevant.
  2. If the eligible participant is interested to learn more about the research project, the HCP will, with their approval, provide their Danish Personal Identification Number (CPR number) and contact information (phone/email) to the investigator group.
  3. When the investigators receives information on the eligible participant, written information material will be sent to the eligible participant through a secure system (eBoks).
  4. A research assistent from the investigator group will contact (via phone) the eligible participant, to schedule a video consultation.
  5. During the video consultation, a research assistant from the investigator group will provide verbal information about the project. The eligible participant will receive a presentation of the programme and guidance on how to log in and will also have the opportunity to ask questions. Finally study eligibility will be re-assessed and confirmed by the researcher.
  6. After ensuring that sufficient verbal information has been provided, informed consent will be obtained. Written consent forms will be collected electronically via a unique link to the consent form hosted on the secure web-based data collection platform, REDCap.
  7. Once written consent is obtained, a research assistent from the investigator group will provide the participant with a login code (via e-Boks) to access the programme at www.mine-symptomer.dk. The research assistent will encourage the participant to log in to the programme within a few days.
  8. The research assistent will notify the referring HCP about participation (via phone or email).
  9. The HCP will then document the referral in the participant's medical journal.

When the participant has signed the consent form, they login to a web portal via the website and access the internet-based programme. The programme is secured by two-factor authentication. The participant login with an unique national electronic identifier (MitID) and a code subsequently provided by the app MitID. Finally, they will need to provide the code provided by the research assistent. At first login, the participant will need to complete a set of questionnaires before accessing the programme. When completed the participant receives access to the programme. The research assistent will follow up with participants by phone after one week if they have not logged into the programme and after three weeks if they have logged in but remained inactive. Participants can decide individually how long they wish to use the programme, but they are encouraged and recommended to engage actively at least twice a week for a minimum of 30 minutes.

The research assistent will contact all participants for an end-of-treatment interview (8 weeks after baseline). The interview will be conducted via telephone and will not be recorded. The aim will be to gather their overall feedback/comments on the programme, and to recommend that the participant engage in a follow-up consultation with their referring HCP. Additionally, participants will be reminded to complete the End of Treatment questionnaire (8 weeks after baseline), and the 3-months follow up questionnaire, which will be delivered via e-Boks.

DATA COLLECTION The study will make use of self-reported questionnaire data from the participating young person and data retrieved from the My Symptoms Young-programme. Participant questionnaires will be administered at baseline (first login to the programme), Endof Treatment (8 weeks after baseline) and 3 months follow-up after End of Treatment. Participant data from the internet-based programme will also be retrieved at End of Treatment (8 weeks after baseline).

Self-report questionnaires

Time points of questionnaire distribution:

Time point 1: Baseline (first login to the programme) Time point 2: End of Treatment (corresponding to 8 weeks after first login) Time point 3: 3-month follow-up after End of Treatment.

Data retrieved from the internet-based programme

The investigators will keep track of young person's eventually accepting and logging into the programme and describe their use of the programme. Their work is logged with regard to:

  • Number of logins
  • Number of days with login
  • Number of modules visited
  • Number of visits on every single "page" in the programme
  • Number of exercises created using the provided tools.
  • Total time spent in the programme
  • Time spent per programme module.

INTERVENTION The development of the intervention My Symptoms Young and the subsequent evaluation follows the principles for complex interventions as suggested by the Medical Research Council (MRC-guideline) in 2021.

Development of the My Symptoms Young The current project has been preceded by an iterative development of the first prototype of the intervention supported by the Quality Improvement Committee for General Practice of the Region of Southern Denmark (Kvalitets- og Efteruddannelsesudvalget i Region Syddanmark), J.no.: 20/37140 and the joint regional fund under Danish Regions (Den fælles regionale pulje under Danske Regioner), J. no. EMN-2019-00852 1310643. My Symptoms Young is based on the existing My Symptoms programme for adults and is through user involvement and usability testing redesigned to meet the specific needs of young people.

The process involved a review of evidence on existing self-help interventions for young people with PPS, identification of specific user needs through a qualitative interview study with 11 young people with PPS and usability testing in the further development and refinement of the content of the self-help intervention. Specific modifications have included reduction and simplification of text, adaption of case stories to content relevant for the age group, more focus on suggesting involvement of the family and other close relatives in the programme content and exercises to get support and encouragement.

Content of 'My Symptoms Young' My Symptoms Young is an internet-based self-help programme developed specifically to young persons with moderate PPS seen in primary care. It is designed so the HCP can refer the young person to the programme, when the HCP finds it relevant according to the guiding in- and exclusion criteria.

The young person will get access to an advanced internet-based programme consisting of seven modules, a closing module on relapse prevention, and a module targeting close relatives plus four tools: don't break the chain, goal setting staircase, symptom registration and notebook for reflections. The seven modules target symptom understanding, physical energy, resources and strains, thoughts, feelings, values, and self-care. Participants will gradually gain access to the modules.

The module for close relatives is designed to inform them about the program's content and what participants will experience. It also provides advice and guidance for relatives to support participants in successfully completing the programme. The closing module targets questions for reflection on personal outcome, statistics on work in the programme, results on the Bodily Distress Syndrome (BDS) checklist and relapse prevention. The programme encourages young persons to work with various exercises throughout the different modules but with freedom to choose what to work with. Besides text and exercises, the programme also includes explanatory animations, audio files on case stories, audio files on brief meditations and videos on physical exercises.

ANALYSIS AND STATSTICS Descriptive analyses of participant characteristics, primary and secondary outcomes, and HL and aspects of eHL will be performed at baseline. Linear regression models will be used to analyze the potential changes in outcomes from pre-treatment to post-treatment and three months follow-up. Levels of HL and eHL, respectively, will be added as continuous scores in separate analyses to test their impact on outcomes. If feasible the analyses will be adjusted for sociodemographic characteristics and presence of chronic disease.

Sample size calculation: Sample size is based on a power analysis performed for the adult programme My Symptoms using the same primary outcome, i.e. symptom intensity: detecting a true change in the primary outcome with a probability of 80%, alpha level set at 0.05 and the correlation between measurements in the same individual at baseline and post-treatment assumed to be 0.7, a minimum sample size of 62 would be required, assuming a mean difference of 0.52 and a standard deviation of 0.14 (based on effects reported on eHealth treatment for adults with chronic pain).

ETHICS AND DATA PROTECTION The study will be conducted in accordance with the Declaration of Helsinki and has received approval from the Research Ethics Committee of the Central Denmark Region (reference no. 1-10-72-52-25).

The study has also been registered in the Central Denmark Region's internal research project register (reference no. 1-16-02-266-25) and in Aarhus University's record of processing activities in accordance with Article 30 of the General Data Protection Regulation (GDPR) (reference no. 2022-0367531, registration no. 3892).

All personal data will be processed in compliance with the GDPR and the Danish Data Protection Act, including Section 10, which regulates the processing of personal data for scientific research purposes. Participants will receive written information about the study, including how their personal data will be processed.

EXPECTED OUTCOMES Overall, the intervention is expected to improve the health of young persons with bodily distress in the form of PPS, their functioning and quality of life at an early stage, i.e. before the symptoms become chronic. As part of symptom assessment and management, the HCP will have to draw on physical examinations and potential biomedical investigations etc., but the current programme may both empower the young person and improve how the HCPs in primary care communicate with young people about PPS, hence have the potential to reduce the use of health care, improve symptom coping and illness perception.

The investigators expect the intervention to be able to reduce symptom intensity and interference with daily activities. Over time the investigators expect a reduce in health care use. Thus, part of the idea behind the programme is to move time-consuming information about symptoms from the consultation to the young person's home. Use of primary care may increase temporarily as seen in previous intervention studies, but use of secondary hospital-based health care is expected to decrease.

ADVERSE EVENTS There are no expected side effects or risks in participating in the study. Thus, there are no known harmful effects of internet-based self-help interventions to young people, neither short nor long-term. The disadvantage of participation is mainly the need to spend time with the programme and the scientific evaluation (questionnaires).

02

Conditions studied

  • Persistent Physical Symptoms (PPS)
  • Bodily Distress Syndrome
  • Health Literacy
  • eHealth Literacy

Browse trials for

Keywords

  • Persistent physical symptoms
  • Young people
  • Internetbased interventions
  • Bodily distress
  • Health literacy
  • eHealth literacy
  • iCBT
03

In context

Literacy

201 studies on the registry are indexed under Literacy; 69 are open to participants now.

This study's planned enrollment of 62 is below the median of 124 across 170 interventional studies indexed under Literacy.

Browse Literacy studies →

Lead sponsor

Aarhus University Hospital is the lead sponsor of 298 studies on the registry; 80 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age: 15-25 years
  • Persistent or recurrent physical symptoms (PPS) ≥ 3 months
  • Average symptom intensity and interference of ≥ 3 on the NRS scale (0-10)
  • PPS affecting daily activities (e.g. school attendance, social activities, hobbies)
  • Symptoms are not explained by existing physical disease
  • Reads, speaks, and understands Danish

Exclusion criteria

Exclusion Criteria:

  • Severe psychiatric or social problems (e.g. acutely suicidal, psychotic)
  • Problematic use of alcohol or drugs
  • Insufficient digital skills
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
62 participants (estimated)

Study arms

  • Experimental
    My Symptoms Young Participants

    Participants aged 15-25 experiencing persistent physical symptoms (≥3 months), referred to the 8-week internet-based intervention My Symptoms Young.

    Other: My Symptoms Young - an internet-based self-help programme for young people with persistent physical symptoms

Interventions

  • OtherMy Symptoms Young - an internet-based self-help programme for young people with persistent physical symptoms

    My Symptoms Young is advanced internet-based self-help programme consisting of seven modules, a closing module on relapse prevention, and a module targeting close relatives plus four tools: don't break the chain, goal setting staircase, symptom registration and notebook for reflections. The seven modules target symptom understanding, physical energy, resources and strains, thoughts, feelings, values, and self-care. The program is accessed through a website using either a computer, tablet or mobile phone.

06

What researchers measure

Primary outcomes

  1. Symptom intensity and interference

    The primary outcomes will be symptom intensity and symptom interference with daily activities as measured by a numeric rating scale (NRS) ranging from 0 to 10. For symptom intensity, the young person rates the overall intensity of their bodily symptoms within the past 7 days where 0 represents 'no symptoms at all' and 10 'worst possible symptoms'. For symptom interference, the young person indicates their bodily symptoms' interference with daily activities within the past 7 days, 0 will represent 'Not at all' and 10 'Interfered completely'

    Time frame: Baseline (first login in programme), End of Treatment (8 weeks after baseline), 3-months after End of Treatment

Secondary outcomes

  1. SF-36

    Two items from the SF-36 score will be used to measure overall global health. The first item is "In general, would you say your health is" and is rated on a Likert scale 1 (excellent), 2 (very good), 3 (good), 4 (fair) and 5 (poor). The second item is "Compared to one year ago, how would you rate your health in general now". The item is rated on a Likert scale ranging from 1 (much better now than one year ago), 2 (somewhat better now than one year ago), 3 (about the same), 4 (somewhat worse now than one year ago) and 5 (much worse now than one year ago)

    Time frame: Baseline (first login in programme), End of Treatment (8 weeks after baseline), 3-months after End of Treatment

  2. The Bodily Distress Syndrome (BDS) Checklist

    The Bodily Distress Syndrome (BDS) Checklist will be administered as a measure of physical symptom burden. The BDS Checklist explores the presence of 25 symptoms representing four symptom clusters: cardiopulmonary, gastrointestinal, musculoskeletal, and general symptoms. The young person will be asked to rate on a 5-point Likert-type scale how much they have been bothered by each of the 25 listed symptoms within the past four weeks. Response categories are: 'not at all' (0), 'a bit' (1), 'somewhat' (2), 'quite a bit' (3) and 'a lot' (4). The sum score will be calculated by adding the single item scores from the 25 items (range 0-100) with higher scores representing higher symptom burden.

    Time frame: Baseline (first login in programme), End of Treatment (8 weeks after baseline), 3-months after End of Treatment

  3. The Limitation Index (LI-index)

    Impact on physical functioning will be measured using the Limitation Index (LI-index). The questionnaire is a modified version of the Pain Interference Index (PII), which emphasizes symptoms beyond just pain. The PII was developed as a brief instrument to assess the impact of pain on behaviours and the extent to which long-standing pain interferes with essential aspects of daily life. The modified LI-index consist of six items that measures the extent to which physical symptoms have limited behaviour within the past four weeks. The items are rated on a Likert scale ranging from 0 ('not at all') to 6 ('very much').

    Time frame: Baseline (first login in programme), End of Treatment (8 weeks after baseline), 3-months after End of Treatment

  4. Patient Global Impression of Change (PGIC)

    Self-rated global health change will be obtained using the Patient Global Impression of Change (PGIC) scale. The young person will be asked to rate current health condition on a five-point Likert scale ranging from much worse to much better health. For statistical analysis, the scale will be collapsed into three categories representing much improved, minimal or no change and much deteriorated health. Based on the NRS of symptom intensity, the proportion of young persons that has clinically significantly improved will be calculated. Clinically significant improvement will be defined as a decrease in symptom intensity of ≥2.0 points. Adverse events will be defined as a 50% worsening of symptoms as measured by the NRS for symptom intensity.

    Time frame: End of Treatment (8 weeks after baseline), 3-months after End of Treatment

  5. The Brief Illness Perception Questionnaire (B-IPQ)

    To measure illness perception, an adapted version of the Brief Illness Perception Questionnaire (B-IPQ) will be used. The original B-IPQ has 9 items; 5 items assess cognitive illness representations such as consequences, timeline, personal and treatment control, and identity. Two items assess emotional representations such as concerns and emotions and finally, illness comprehensibility and illness causes are assessed by one item respectively. Apart from illness causes, each item is scored on a scale ranging from 0-10. PPS is not an illness per se and young persons with PPS may not have a diagnosis. Therefore, the investigators have replaced the term 'illness' with 'symptoms'. Therefore, one item 'How much do you experience symptoms from your illness?' has been removed. A total score (range 0-70) will be calculated with lower scores indicating more positive illness perceptions.

    Time frame: Baseline (first login in programme), End of Treatment (8 weeks after baseline), 3-months after End of Treatment

  6. The Behavior Related to Illness Questionnaire (BRIQ)

    Two subscales from the Behaviour Related to Illness Questionnaire (BRIQ) will be applied to measure behavioural responses to PPS within the past four weeks. The subscale "Limiting behaviour" comprises 6 items and the subscale "All or nothing behaviour" 7 items. All items are scored on a 5-point Likert-type scale representing the frequency of certain behaviours and ranging from 0 ('not at all') to 4 ('every day'). For each subscale, a sum score will be calculated with lower scores indicating a more adaptive symptom behaviour.

    Time frame: Baseline (first login in programme), End of Treatment (8 weeks after baseline), 3-months after End of Treatment

  7. Pain Self-Efficacy Questionnaire (PSEQ)

    To measure participants' current confidence in performing activities in the context of PPS, an adapted version of the Pain Self-Efficacy Questionnaire (PSEQ) is used. To address young people with PPS, the term 'pain' has been replaced by 'symptoms'. The PSEQ comprises ten items that are scored on a 7-point Likert-type scale ranging from 0 ('not at all confident') to 6 ('completely confident'). A sum score (range 0-60) will be calculated.

    Time frame: Baseline (first login in programme), End of Treatment (8 weeks after baseline), 3-months after End of Treatment

  8. Whiteley Index (WI-6-R)

    Illness worry is measured using the revised version of the six-item Whiteley Index (WI-6-R). The WI-6-R measures to which extent the respondent within the past four weeks has been bothered by fear of being ill and has attributed current bodily sensations to physical disease. The six items are rated on a Likert-type scale ranging from 0 ('not at all') to 4 ('very much'). A sum score (range 0-24) will be calculated with higher scores indicating higher illness worry.

    Time frame: Baseline (first login in programme), End of Treatment (8 weeks after baseline), 3-months after End of Treatment

  9. Symptom Checklist (SCL-90)

    Impairment by anxiety and depression will be measured with subscales from the Danish version of the Hopkins Symptom Checklist (SCL-90), the SCL-ANX4 for anxiety and the SCL-DEP6 for depression. Each item in these subscales relates to the past four weeks and is rated on a five-point Likert scale of distress ranging from 'not at all' (0) to 'very much' (4). The total sum scores will be calculated for each subscale (range: anxiety 0-16, depression 0-24). Higher scores indicate higher impairment. Hopelessness will be measured by one item from the SCL-90: "During the last four weeks, how much were you bothered by feelings of hopelessness about the future?". Response categories are measured on a five-point Likert scale ranging from 'not at all' (0) to 'very much' (4).

    Time frame: Baseline (first login in programme), End of Treatment (8 weeks after baseline), 3-months after End of Treatment

  10. Use of health care services

    Twelve individual items will be used to assess participants' use of healthcare services and medication consumption over the past three months. Eight items refer to the number of consultations participants have had with various healthcare professionals, including general practitioners, social workers, manual therapists, occupational therapists, dietitians, alternative practitioners, psychologists, psychotherapists, or psychiatrists, and private specialist doctors. Participants can either indicate that they have had no consultations at all or specify the number of visits. Additionally, three items assess whether participants have visited an emergency department, had outpatient consultations, or been hospitalized. The response categories are the same as in the previous section. Finally, one item evaluates medication consumption. Participants will be asked whether they have taken painkillers, medication for anxiety or depression, diuretics, weight-loss medication, or protein supplements.

    Time frame: Baseline (first login in programme), 3-months after End of Treatment

Other outcomes

  1. Participant expectancy

    To measure the young person's credibility and expectancy before the self-help intervention start, two ad hoc items has been developed inspired by the Credibility and Expectancy Questionnaire. These two items are: "1) How meaningful does this self-help programme offered to you seem?" and "2) How efficient do you think this self-help programme will be in reducing your symptoms?" A scale ranging from 'not meaningful at all'/not efficient at all' (1) to 'highly meaningful'/'highly efficient' (10) will be provided.

    Time frame: Baseline (first login in programme)

  2. Program evaluation

    Participants will be asked to evaluate the My Symptoms Young programme with regard to ease of use (one item), overall benefit from the programme (one item), each of its seven modules (7 items) and the four main tools that support participant activity and monitoring throughout the programme: the goal ladder, the don't break the chain, the symptom registration tool and the notebook (4 items). All items are scored on a five-point Likert-type scale representing the extent to which the young person find the programme easy to use or has experienced benefit. The scale ranges from 'not at all' (0) to 'to a very great extent' (4). Finally, the young person is asked to indicate on a VAS scale (0-10), whether they would recommend the treatment programme to a friend with similar problems.

    Time frame: End of Treatment (8 weeks after baseline)

  3. Brief Health Literacy Scale for Adults (B-HLA)

    To measure participants' overall health literacy, we will use the Brief Health Literacy Scale for Adults (B-HLA). B-HLA is a validated tool for adults developed based on the HLSAC questionnaire, which is a widely used and validated instrument for assessing health literacy in children. The B-HLA consists of 10 questions covering five theoretical components of health literacy: knowledge, practical knowledge, critical thinking, self-awareness, and community engagement. The tool was translated and validated for the Danish context in 2023. Responses are rated on a four-point scale: Not at all true, not quite true, somewhat true, and completely true. The total score ranges from 10 to 40 points and can be categorized into three levels of health literacy: low (10-25), moderate (26-35), and high (36-40).

    Time frame: Baseline (first login in programme)

  4. The eHealth Literacy Questionnaire (eHLQ)

    To assess the extent to which participants feel motivated to use digital tools for managing their health, the investigators will use a scale from the eHealth Literacy Questionnaire (eHLQ). The eHLQ consists of seven scales with a total of 35 items and is used to map experiences related to finding, understanding, and using digital health information, managing one's own health, and communicating with healthcare professionals. The investigators will use only scale 5, "Motivated to engage with digital services," which includes five items. Responses are rated on a four-point scale: strongly disagree, disagree, agree, and strongly agree.

    Time frame: Baseline (first login in programme)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Christensen OR, Hedegaard L, Rask MT, Clemensen J, Frostholm L, Rosendal M. Designing and Developing an eHealth Program for Patients With Persistent Physical Symptoms: Usability Study. JMIR Hum Factors. 2023 Feb 8;10:e42572. doi: 10.2196/42572. PubMed 36753312 ↗
  • Vigerland S, Lenhard F, Bonnert M, Lalouni M, Hedman E, Ahlen J, Olen O, Serlachius E, Ljotsson B. Internet-delivered cognitive behavior therapy for children and adolescents: A systematic review and meta-analysis. Clin Psychol Rev. 2016 Dec;50:1-10. doi: 10.1016/j.cpr.2016.09.005. Epub 2016 Sep 20. PubMed 27668988 ↗
  • Rosendal M, Blankenstein AH, Morriss R, Fink P, Sharpe M, Burton C. Enhanced care by generalists for functional somatic symptoms and disorders in primary care. Cochrane Database Syst Rev. 2013 Oct 18;2013(10):CD008142. doi: 10.1002/14651858.CD008142.pub2. PubMed 24142886 ↗
  • Aaby A, Friis K, Christensen B, Rowlands G, Maindal HT. Health literacy is associated with health behaviour and self-reported health: A large population-based study in individuals with cardiovascular disease. Eur J Prev Cardiol. 2017 Nov;24(17):1880-1888. doi: 10.1177/2047487317729538. Epub 2017 Aug 31. PubMed 28854822 ↗
  • Andersen JH, Risor MB, Frostholm L, Rask MT, Rosendal M, Rask CU. Managing persistent physical symptoms when being social and active is the norm: a qualitative study among young people in Denmark. BMC Public Health. 2023 Oct 7;23(1):1949. doi: 10.1186/s12889-023-16910-2. PubMed 37805452 ↗
  • Rask MT, Jakobsen PR, Clemensen J, Rosendal M, Frostholm L. Development of an eHealth programme for self-management of persistent physical symptoms: a qualitative study on user needs in general practice. BMC Fam Pract. 2021 Feb 7;22(1):33. doi: 10.1186/s12875-021-01380-5. PubMed 33550988 ↗
  • Holsting AF, Rask MT, Frostholm L, Rosendal M, Rask CU. Self-help interventions for young people with persistent physical symptoms: A systematic review. J Psychosom Res. 2021 Sep;148:110553. doi: 10.1016/j.jpsychores.2021.110553. Epub 2021 Jun 19. PubMed 34242894 ↗
  • Rask MT, Rosendal M, Fenger-Gron M, Bro F, Ornbol E, Fink P. Sick leave and work disability in primary care patients with recent-onset multiple medically unexplained symptoms and persistent somatoform disorders: a 10-year follow-up of the FIP study. Gen Hosp Psychiatry. 2015 Jan-Feb;37(1):53-9. doi: 10.1016/j.genhosppsych.2014.10.007. Epub 2014 Oct 22. PubMed 25456975 ↗
  • Murray CB, Groenewald CB, de la Vega R, Palermo TM. Long-term impact of adolescent chronic pain on young adult educational, vocational, and social outcomes. Pain. 2020 Feb;161(2):439-445. doi: 10.1097/j.pain.0000000000001732. PubMed 31651579 ↗
  • Kozlowska K. Functional somatic symptoms in childhood and adolescence. Curr Opin Psychiatry. 2013 Sep;26(5):485-92. doi: 10.1097/YCO.0b013e3283642ca0. PubMed 23867659 ↗
  • Klastrup LK, Rosendal M, Rask MT, Christensen KS, Rask CU. Functional somatic symptoms in youths in general practice: A cross-sectional study on prevalence, clinical management and perceived burden. J Psychosom Res. 2022 May;156:110765. doi: 10.1016/j.jpsychores.2022.110765. Epub 2022 Feb 24. PubMed 35276589 ↗

Related links

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2025 (actual). Primary completion is estimated for Sep 2027, 22 months after the start.

Of 115 non-industry interventional studies with no phase under Literacy, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 20. This study's planned 22 months is above that.

Counting every sponsor, half of 117 studies reached it within 11 months; a quarter within 4 and three quarters within 19.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 26, 2026
First posted
Nov 3, 2026
StartActual
Nov 28, 2025
Primary completionEst.
Sep 30, 2027
CompletionEst.
Dec 31, 2029
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07912515
Responsible party
Charlotte Ulrikka Rask (Professor, Aarhus University Hospital) — Principal investigator
First posted
Nov 3, 2026
Start date
Nov 28, 2025
Primary completion
Sep 30, 2027 (estimated)
Completion
Dec 31, 2029 (estimated)
Last update
Nov 3, 2026

Study contacts

Nina Maindal
Contact
ninmai@rm.dk
0045 61379813
Charlotte Ulrikka Rask, Professor
Contact
charrask@rm.dk

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion